Washington [US], September 3 (ANI): Researchers at the Washington University School of Medicine in St. Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation. The goal of the research was to develop rheumatoid arthritis therapies with minimal side effects.
\
\
\
\
